Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ory

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cancer|November 5, 2005
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing miceBenjamin Ory, Marie-Françoise Heymann, Akira Kamijo, et al.
Cells|April 2, 2020
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone SarcomasCamille Jacques, Robel Tesfaye, Melanie Lavaud, et al.
Epigenomics|December 19, 2019
BET bromodomains' functions in bone-related pathologiesCamille Jacques, Melanie Lavaud, Steven Georges, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Murine Models of Bone SarcomasCamille Jacques, Nathalie Renema, Benjamin Ory, et al.
European Journal of Medicinal Chemistry|November 1, 2020
Development of prohibitin ligands against osteoporosisRedouane Tabti, François Lamoureux, Céline Charrier, et al.
Biochemical Pharmacology|October 22, 2021
Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?Mathilde Mullard, Mélanie Lavaud, Laura Regnier, et al.
Cancers|July 27, 2022
Origin and Therapies of OsteosarcomaBrice Moukengue, Morgane Lallier, Louise Marchandet, et al.
Cells|September 16, 2020
Ribosomopathies: New Therapeutic PerspectivesEmilien Orgebin, François Lamoureux, Bertrand Isidor, et al.
Oncotarget|August 4, 2016
miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumorsCamille Jacques, Lidia Rodriguez Calleja, Marc Baud'huin, et al.
Cells|April 3, 2021
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic IssuesMorgane Lallier, Louise Marchandet, Brice Moukengue, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cancer|November 5, 2005
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing miceBenjamin Ory, Marie-Françoise Heymann, Akira Kamijo, et al.
Cells|April 2, 2020
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone SarcomasCamille Jacques, Robel Tesfaye, Melanie Lavaud, et al.
Epigenomics|December 19, 2019
BET bromodomains' functions in bone-related pathologiesCamille Jacques, Melanie Lavaud, Steven Georges, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 8, 2019
Murine Models of Bone SarcomasCamille Jacques, Nathalie Renema, Benjamin Ory, et al.
European Journal of Medicinal Chemistry|November 1, 2020
Development of prohibitin ligands against osteoporosisRedouane Tabti, François Lamoureux, Céline Charrier, et al.
Biochemical Pharmacology|October 22, 2021
Ubiquitin-specific proteases as therapeutic targets in paediatric primary bone tumours?Mathilde Mullard, Mélanie Lavaud, Laura Regnier, et al.
Cancers|July 27, 2022
Origin and Therapies of OsteosarcomaBrice Moukengue, Morgane Lallier, Louise Marchandet, et al.
Cells|September 16, 2020
Ribosomopathies: New Therapeutic PerspectivesEmilien Orgebin, François Lamoureux, Bertrand Isidor, et al.
Oncotarget|August 4, 2016
miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumorsCamille Jacques, Lidia Rodriguez Calleja, Marc Baud'huin, et al.
Cells|April 3, 2021
Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic IssuesMorgane Lallier, Louise Marchandet, Brice Moukengue, et al.
Pageof 6